Nunzia Caporarello, Ph.D.

Institution: Mayo Clinic

Project: Targeting vascular rarefaction and loss of endothelial identity in pulmonary fibrosis

Grant(s): Dalsemer Grant

Idiopathic pulmonary fibrosis is a chronic lung disease that causes scarring of the lungs, leading to organ failure and death. Therapies to treat this disease are limited, making further studies on mechanisms responsible for the disease a priority. Although pulmonary blood vessels are abundant in the lungs and contribute to regeneration and repair of adult organs, including lungs, their role in pulmonary fibrosis is mostly unknown. We will investigate the role of ERG, a gene which controls the function and the biology of the endothelial cells (the cells forming the blood vessels), in regulating the development of pulmonary fibrosis. We will define ERG’s role as a potential therapeutic target which will restore the stability of endothelial cells and promote resolution of the disease.

Freedom From Smoking Clinic
, | Sep 29, 2021
Community Connections: The Path To Clean Air
, | Oct 06, 2021